The Mechanism, Clinical Efficacy, Safety, and Dosage Regimen of Atomoxetine for ADHD Therapy in Children: A Narrative Review

Atomoxetine, a selective norepinephrine (NE) reuptake inhibitor, was approved for attention deficit/hyperactivity disorder (ADHD) treatment in children, adolescents and adults. We searched the database PubMed/MEDLINE (2000 to October 1, 2021). Only publications in English were considered. Atomoxetin...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Di, Wu, Dan-Dan, Guo, Hong-Li, Hu, Ya-Hui, Xia, Ying, Ji, Xing, Fang, Wei-Rong, Li, Yun-Man, Xu, Jing, Chen, Feng, Liu, Qian-Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863678/
https://www.ncbi.nlm.nih.gov/pubmed/35222104
http://dx.doi.org/10.3389/fpsyt.2021.780921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863678/
https://www.ncbi.nlm.nih.gov/pubmed/35222104
http://dx.doi.org/10.3389/fpsyt.2021.780921

Ejemplares similares